データなし
データなし
Gyre Therapeutics Shares Are Trading Lower After the Company Reported a Year-over-year Decline in Q3 Financial Results.
Earnings Flash (GYRE) GYRE THERAPEUTICS Posts Q3 Revenue $25.5M
Public Companies Among Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 6.9% Last Week
Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) Market Cap Dropped US$51m Last Week; Public Companies Bore the Brunt
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
データなし
データなし